New Therapeutic Solutions
Embedded Files
NANO. TARGETED. INTELLIGENT.
ArthroTarget is developing a magnetically controllable nanoparticle platform aimed at investigating future targeted and minimally invasive therapies.
👥
Around 600 million people worldwide and 17.9% of adults in Germany live with osteoarthritis and similar joint diseases.
❌
Numerous existing therapies do not provide long-term relief. Patients undergo expensive, painful, and often ineffective treatments.
💶
Access to innovative methods is often limited to those who can afford it. This burdens not only the patients but the entire healthcare system.
⏳
Valuable time, money, and medical personnel are wasted through unsystematic, non-targeted therapies.
Why ArthroTarget?
Research Areas & Concepts*
Conceptual approaches for addressable nanoplatforms within the scope of early research.
Addressable Nanoplatforms
Within the framework of early research, conceptual approaches for addressable nanoplatforms are being investigated. The focus is on fundamental system architecture.
Local Application Approaches
In a research context, potential application approaches are considered conceptually, including local and non-systemic formulations.
Precise Targeting
Theoretical concepts for the targeting of drug delivery systems are investigated without commitment to specific application mechanisms.
Time-Dependent Release Profiles
As part of conceptual research, time-dependent drug release profiles of addressable systems are being modeled and studied.
Integrated into a robust ecosystem of research and innovation
Page updated
Report abuse